The aim of the study is to examine the tolerability and abuse potential of the diluted
methadone solution (5 mg/ml → 2 mg/ml) in combination with naloxone in opioid substitution
treatment.
Study hypothesis: Treatment with this diluted combination product is safer than with
methadone alone (5 mg/ml) and combination product does not precipitate withdrawal symptoms in
opioid dependent patients.